Autism is a developmental disorder defined by the presence of a triad of communication, social and stereotypical behavioral characteristics with onset before 3 years of age. Autism may be a component feature of several genetic disorders, and underlying the remaining cases of autism are undoubtedly multiple etiologies. In spite of the fact that there are various etiologies for autistic behavior, the possibility of a common neurochemical mechanistic feature, shared by multiple causes of autism, cannot be excluded. It is upon this premise that functional neuroimaging of groups of autistic subjects of unknown etiology is compared to nonautistic control groups in search of common biological substrates.
We have demonstrated developmental changes in serotonin synthesis capacity in children using ␣[C-11]methyl-L-tryptophan and positron emission tomography. 1 Global brain values for serotonin synthesis capacity (K-complex) were obtained for autistic children (n = 28), their non-autistic siblings (n = 8), and epileptic children without autism (n = 16). K-complex values were plotted according to age to determine developmental changes and differences in serotonin synthesis between groups. For non-autistic children, serotonin synthesis capacity was Ͼ200% of adult values until the age of 5 years and then declined toward adult values. In autistic children, serotonin synthesis capacity increased gradually between the ages of 2 years and 11 years to values one and a half times adult normal values. In addition, we demonstrated asymmetries of ␣[C-11]methyl-L-tryptophan standard uptake value (SUV) in frontal cortex, thalamus and cerebellum in autistic children. 2 These data suggest that humans undergo a period of high brain serotonin synthesis capacity during childhood, and that this developmental process is disrupted in autistic children with some brain regions more severely impacted.
Evidence from both pharmacological and knock-out experiments demonstrates that serotonin plays a role in modulation of synaptogenesis. 3, 4 Two groups first showed that this transient innervation actually represents transient expression of the high-affinity serotonin transporter and vesicular monoamine transporter by glutamergic thalamocortical neurons. 5, 6 During this period, these thalamo-cortical neurons take up and store serotonin, although they do not synthesize serotonin. While the role of serotonin in glutamatergic neurons whose cell bodies are located in sensory nuclei of the thalamus is not yet known, there is evidence that the serotonin concentration must be neither too high nor too low during this period. Depletion of serotonin delays the development of the barrel fields of the rat somatosensory cortex 7, 8 and decreases the size of the barrel fields. 9 Conversely, increased serotonin during this critical period, as in the monoamine oxidase A (MAOA) knock-out mouse, results in increased tangential arborization of these axons resulting in blurring of the boundaries of the cortical barrels. 10 Expression of a polymorphism of the serotonin transporter in autism 11, 12 may result in altered serotonin modulation of thalamo-cortical connectivity, thus possibly accounting for abnormal sensory perception reported in many autistic subjects. 13 Decreased or increased brain serotonin during this period of development results in disruption of synaptic connectivity in sensory cortices. 4, 9, 10 The effect of serotonin on synaptogenesis is not limited to the sensory cortices. For example, Yan et al 14 have reported that depletion of serotonin with PCA or 5,7-dihydroxytryptamine in neonatal rat pups resulted in large decreases in the numbers of dendritic spines in hippocampus.
The description of changes in all serotonin receptors during development is beyond the scope of this short review. I focus on the 5HT1A receptor because changes in this receptor show important relationships to brain regions showing abnormalities in autism. In the adult rodent brain, 5HT1A receptor binding and immunoreactivity are high in limbic brain regions (including lateral septum, CA1 and dentate gyrus in hippocampus, frontal and entorhinal cortex), raphe nuclei and interpeduncular nucleus. Moderate receptor-like immunoreactivity was reported in some thalamic and hypothalamic nuclei, nucleus of the solitary tract, in dorsal tegmentum, in the nucleus of the trigeminal nerve and in the dorsal horn of the spinal cord. 15 However, during the first 2 postnatal weeks, high concentrations of 5HT1A receptors were transiently expressed in cerebellum, inferior colliculi, and thalamus. Conversely, lower 5HT1A immunoreactivity was measured in cerebral cortex and hippocampus. 16 Transient expression in the cerebellum and thalamus suggest that there is a critical period for trophic actions of serotonin in those Altered brain serotonin mechanisms DC Chugani S17 brain regions. In the cerebellum, mRNA was localized to the molecular/Purkinje cell layer 16 and immunolabeling was localized to the soma and dendrites of Purkinje cells. 17 Localization to Purkinje cells is important in light of consistent reports of decreased numbers of Purkinje cells in brains from autistic individuals. [18] [19] [20] In addition, the enrichment of 5HT1A receptors is most pronounced in the cerebellar vermis in lobules IX and X. 21 Enrichment of 5HT1A receptors in dentate gyrus in hippocampus and in specific lobules of the vermis is interesting in light of reports of hypoplasia dentate gyrus 22 and in the cerebellar vermis in autistic subjects. 23, 24 Studies of changes in 5HT1A receptor expression in human tissue during development are limited. However, there is also evidence for transient expression of 5HT1A binding measured with 8-OH-DPAT 25 and mRNA expression 26 in developing human cerebellum. The highest expression of 5HT1A mRNA was measured in neonatal cerebellar samples, with lower values in children aged 8 months-13 years and no detectable expression in adults. 26 Bar-Peled et al 27 performed autoradiographic binding studies of 5HT1A receptors in fetuses at gestational ages 16-22 weeks and reported higher binding in cortex and hippocampus in the fetuses compared to adults. The time course of the decrease in 5HT1A receptors expression postnatally in humans remains to be determined. However, the time course for developmental changes in cortical synaptic density undergoes a prolonged period in humans with large changes taking place during early childhood. 28 The changes in serotonin receptor density and serotonergic innervation and serotonin synthesis with age suggest that serotonin plays an important role in brain development. Indeed, there is a body of evidence that serotonin regulates several aspects of brain development, including regulation of cell division, differentiation, neurite outgrowth and synaptogenesis. Serotonin influences brain development by regulation of trophic factors and by direct regulation of activitydependent plasticity. There is evidence that one mechanism by which serotonin has trophic effects during brain development is through the regulation of trophic factors such as 5HT1A mediated release of S100 29 and brain derived neurotrophic factor. 30 Serotonin and changes in serotonin during development have effects on long term potentiation. The effect of serotonin on long term potentiation has been documented in several brain regions, including somatosensory cortex, 31 visual cortex, 32 spinal cord 33 and hippocampus. 34 Evidence for serotonergic modulation of synaptic development has been demonstrated for the lateral superior olive in developing gerbils 35 and for segregation of retinal projections in MAO-A knock-out mice. 36 
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Our finding of altered regulation of serotonin synthesis with age in autistic children together with the important role of serotonin in postnatal brain development suggests an approach for the pharmacological treatment of autism. These studies provide a rationale for trials of serotonergic drugs in very young autistic children in an attempt to alter synaptic plasticity during postnatal development.
